冠昊生物(300238.SZ):控股股東廣東知光已增持1.14%股份
格隆匯1月20日丨冠昊生物(300238.SZ)公佈,公司控股股東廣東知光或實際控制人計劃自2019年5月7日起六個月內,擬增持股份數量不超過公司總股本的2.14%、不低於總股本的1.1%;此後,廣東知光計劃將增持計劃的期限延長5個月,即此次增持計劃延期至2020年4月7日。
截至目前,此次增持計劃延期增持時間已過半,公司控股股東廣東知光通過“雲信—弘瑞29號集合資金信託計劃”以集中競價的方式累計增持公司股份301.9032萬股,佔公司總股本的1.14%。
此次增持後,廣東知光直接持有公司股份5504.4822萬股,通過“雲信—弘瑞29號集合資金信託計劃”間接持有公司股份1165.7259萬股,合計共持有公司股份6670.2081萬股,佔公司總股本的25.16%;其一致行動人張永明、林玲夫婦持有公司股份1017.9766萬股,佔公司總股本的3.84%。公司控股股東廣東知光及其一致行動人張永明、林玲夫婦合計持有公司股份7688.1847萬股,佔公司總股本的29.00%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.